Cargando…

Venous malformations: PIK3CA mutations guide new treatments

Detalles Bibliográficos
Autor principal:	Dbouk, Hashem A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226472/ https://www.ncbi.nlm.nih.gov/pubmed/27447853 http://dx.doi.org/10.18632/oncotarget.9252

Ejemplares similares

Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
por: Le Cras, Timothy D., et al.
Publicado: (2020)

PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations
por: Blesinger, Hannah, et al.
Publicado: (2018)

Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation
por: Martinez-Corral, Ines, et al.
Publicado: (2020)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come
por: De Mattos-Arruda, Leticia
Publicado: (2020)

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
por: Sterba, Martin, et al.
Publicado: (2023)

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations
por: Brouillard, Pascal, et al.
Publicado: (2021)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

PIK3CA Mutations in Hepatocellular Carcinoma in Korea
por: Kim, Heesue, et al.
Publicado: (2013)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

PIK3CA mutation and colorectal cancer precision medicine
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
por: Deshpande, Vikram, et al.
Publicado: (2011)

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
por: Janku, Filip, et al.
Publicado: (2012)

Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations
por: Park, Hyun Jin, et al.
Publicado: (2020)

PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations
por: di Blasio, Laura, et al.
Publicado: (2018)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
por: Hutchinson, Katherine E., et al.
Publicado: (2023)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

Correlation between circulating cell‐free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA‐mutated metastatic breast cancer
por: Kodahl, Annette R., et al.
Publicado: (2018)

Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly
por: Rios, Jonathan J., et al.
Publicado: (2013)

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases
por: Daneshmand, Manijeh, et al.
Publicado: (2012)

Multiple congenital malformations arise from somatic mosaicism for constitutively active Pik3ca signaling
por: Marechal, Elise, et al.
Publicado: (2022)

Activation of diverse signaling pathways by oncogenic PIK3CA mutations
por: Wu, Xinyan, et al.
Publicado: (2014)

Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
por: Bian, Ji-Lai, et al.
Publicado: (2017)

Image guided sclerotherapy for the treatment of venous malformations
por: Gorman, Johnathon, et al.
Publicado: (2018)

PIK3CA Mutation Analysis in Iranian Patients with Gastric Cancer
por: Iranpour, Mostafa, et al.
Publicado: (2019)

PIK3CA mutation enrichment and quantitation from blood and tissue
por: Keraite, Ieva, et al.
Publicado: (2020)

Frequency and spectrum of PIK3CA somatic mutations in breast cancer
por: Martínez-Sáez, Olga, et al.
Publicado: (2020)

Pulmonary Vein Stenosis Associated with Germline PIK3CA Mutation
por: Yung, Delphine, et al.
Publicado: (2022)

PIK3CA mutations in breast cancer: A Tunisian series
por: Ben Rekaya, Mariem, et al.
Publicado: (2023)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
por: Cocco, Emiliano, et al.
Publicado: (2016)

PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9sbifbbuvecjnh8hsbhf4gkfii